NTxBio Pauses $31 Million Plano Biomanufacturing Project Amid Research Quarter Shift

NtxBio has paused plans to build a roughly $31 million biomanufacturing facility in Plano’s Legacy district, a project that had been expected to bring about 170 jobs and serve as an early anchor for the proposed Texas Research Quarter life-sciences district. The company confirmed the pause in statements reported Jan. 27, 2026, saying it will reassess long-term growth strategy and capital deployment.

The plant was announced in May 2025 and had been scheduled to begin operations in the first quarter of 2026. State economic development materials described the project as more than $31 million in capital investment and said it would create over 170 new jobs. A Texas Enterprise Fund award tied to the project was listed at $1,479,000, a figure media accounts generally rounded to about $1.5 million; local reporting also noted additional City of Plano subsidies had been part of the package.

The pause was framed by company leadership as a timing and capital-allocation decision rather than a cancellation. Joan Haab, identified in reporting as the company’s CEO, said, “At this time, NTx Bio is continuing to evaluate its long-term growth strategy, including potential expansion opportunities in North Texas. While Plano has been an important part of those discussions, we are currently pausing our expansion plans there in 2026. As with many companies in our sector, we are taking a disciplined approach to capital deployment and timing, and we’ll share updates as plans become more defined throughout the year. For now, our focus remains on executing against our current priorities and supporting our core operations. We continue to view North Texas as an attractive life sciences market, and we’ll share more as our plans evolve.”

State officials had touted the investment when it was announced. Governor Greg Abbott said, “Texas is the epicenter for groundbreaking, life-saving medical research and home to thousands of biotech and life science firms,” and added the project “will create over 170 new, good-paying jobs for Texans in our skilled and growing life sciences workforce.” At the time of the award, Dr. Jamie Coffin, identified as NTx’s president and CEO in the state release, said the company would “assemble cutting-edge biomanufacturing instruments that use domestically produced raw materials to advance treatments for cancer and rare diseases while bringing manufacturing and jobs back to the U.S.”

Beyond the company-level decision, the pause arrives as the broader Texas Research Quarter plan is in flux. The proposed $4 billion project, developed by NexPoint, centered on the former EDS/Legacy Drive campus has been reshaped after AT&T announced plans to make the Legacy Drive campus its primary headquarters beginning in 2028, consolidating teams now spread across Dallas, Plano and Irving. Local leaders and developers have described the Research Quarter’s timeline and tenant mix as uncertain in light of those changes.

For Plano residents and local suppliers, the immediate effect is a delay in the expected jobs and contracting opportunities tied to the plant and the Research Quarter pipeline. Key follow-ups include whether the TEF funds have been disbursed, how the City of Plano will respond on local incentives, and whether NexPoint revises the Research Quarter timetable. The pause leaves existing life-sciences momentum in Collin County intact but unsettled, and city and state officials, developers and NTxBio will be watched closely as plans evolve.